This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Hydatigena taeniaeformis Oncosphere Antigen A (ONCA)
Product Overview
BioVenic's Recombinant Hydatigena taeniaeformis Oncosphere Antigen A (ONCA) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 35.51 kDa. The purity is>85% (SDS-PAGE).
Specifications
Target Information
Hydatigena taeniaeformis Oncosphere Antigen A (ONCA) is a key protein in the oncosphere stage of this feline tapeworm. It is highly immunogenic and induces protective immune responses against infection. In veterinary medicine, ONCA is used as a target for vaccine development, with studies showing that recombinant ONCA can reduce infection rates in experimental settings. Additionally, ONCA is valuable for developing diagnostic tools to detect H. taeniaeformis infections in cats and other intermediate hosts. Its role in host-parasite interactions also aids in understanding the pathogenesis of taeniasis.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.